Perspective
Nature Reviews Cancer 5, 397-405 (May 2005) | doi:10.1038/nrc1613
Opinion: Immunotherapy and chemotherapy — a practical partnership
Richard A. Lake1 & Bruce W.S. Robinson2 About the authors
Top of page
Abstract
This article discusses how recent data have altered the way we understand how dying tumour cells, particularly those killed by chemotherapy, engage with antitumour immune responses. These data have significant implications for the development of new protocols combining chemotherapy with immunotherapy, indicating an exciting potential for therapeutic synergy with general applicability to many cancer types.
Author affiliations
- Richard A. Lake is at the Tumour Immunology Group, School of Medicine and Pharmacology, Western Australian Institute for Medical Research, Perth, 6009, Australia.
- Bruce W. S. Robinson is at the School of Medicine and Pharmacology, 4th Floor, G-block, Sir Charles Gairdner Hospital, Nedlands, Perth, 6009, Australia.
Correspondence to: Richard A. Lake1 Email: rlake@cyllene.uwa.edu.au
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
TGFβ is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destructionImmunology and Cell Biology Original Article
See all 24 matches for Research